Lpl Financial LLC G1 Therapeutics, Inc. Transaction History

Lpl Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $12,925 - $42,474	2,500 Added 24.78%	12,590 $157,000
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $3,442 - $4,992	-453 Reduced 4.3%	10,090 $77,000
Q4 2021 Feb 14, 2022	SELL	$10.16 - $16.17 $3,200 - $5,093	-315 Reduced 2.9%	10,543 $108,000
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $7,277 - $12,425	553 Added 5.37%	10,858 $146,000
Q2 2021 Aug 13, 2021	BUY	$19.57 - $26.32 $201,668 - $271,227	10,305 New	10,305 $226,000
Q1 2021 May 14, 2021	SELL	$17.58 - $32.59 $196,720 - $364,682	-11,190 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$10.99 - $20.4 $205,622 - $381,684	-18,710 Reduced 62.58%	11,190 $201,000
Q3 2020 Nov 09, 2020	BUY	$11.55 - $23.75 $345,345 - $710,125	29,900 New	29,900 $345,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.